Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 284-660-7 | CAS number: 84961-70-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute Oral Toxicity
The key study examined the acute oral toxicity of Benzene, mono-C10-13-alkyl derivs., distn. residues (HAB) to rats. A group of 5 male and 5 female rats were given a dose of 2000 mg/kg bw test substance. The animals were examined for clinical symptoms and mortality at 0.5, 1, 2, 3, 4, 5, and 6 hours after application, and then once a day for two weeks. Body weight of the animals was determined on days 0, 7, and 14 of the study. After 14 days, the animals were sacrificed with carbon dioxide and examined macroscopically for recognizable organ defects. No mortality was observed during the study. No adverse effects to body weight or clinical signs were noted. The acute oral LD50 for male and female rats was > 2000 mg/kg bw.
Acute Dermal Toxicity
The key study examined the acute dermal toxicity of Benzene, mono-C10-13-alkyl derivs., distn. residues (HAB). Groups of five male and five female rats were exposed dermally to concentrations of 0 and a limit dose of either 3600 (males) or 4300 mg/kg bw (females). Animals were observed for the next 14 days for mortality and clinical signs and also weighed every 7 days. At the end of the study, animals were necropsied. No mortality was observed during the study, and no adverse clinical signs were noted. Body weight gains of treated animals were also comparable to controls. Doses up to 4300 mg/kg did not cause death or produce clinical, behavioral, or anatomical alterations in female rats. Doses up to 3600 mg/kg bw did not produce adverse effects in male rats. Therefore, the acute dermal LD50 for female rats was > 4300 mg/kg bw, and male rats was > 3600 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Nov. 2, 1992-Nov. 19, 1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Fa. Winkelmann
- Age at study initiation: 6-8 weeks
- Weight at study initiation: 143-167 g males, 129-135 g females
- Fasting period before study: 16 hrs
- Housing: up to 5 animals of the same sex in Makrolon Type III cages, identified by skin and tail markings and cage cards
- Diet (e.g. ad libitum): Ssniff R 10, ad libitum
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 +/- 3
- Humidity (%): 30-70%
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 hrs light/12 hrs dark
IN-LIFE DATES: From: Nov. 3, 1992 To: Nov. 19, 1992 - Route of administration:
- oral: gavage
- Details on oral exposure:
- A volume of 2.33 cm2/kg was applied via intubation to the animals.
- Doses:
- A preliminary dose of 2,000 mg/kg was given orally to 2 male and 2 female rats. For the limit test, 3 male and 3 female rats were given 2,000 mg/kg.
- No. of animals per sex per dose:
- Five of each sex were tested.
- Details on study design:
- The animals were examined for clinical symptoms 0.5, 1, 2, 3, 4, 5, and 6 hours after application, as well as once a day for two weeks. Body weight of the animals was determined on day 0, day 7, and day 14. After 14 days, the animals were sacrificed with carbon dioxide and examined macroscopically for recognizable organ defects.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No mortality was observed during the study.
- Clinical signs:
- other: No adverse symptoms were observed after 14 days of observation.
- Gross pathology:
There were no macroscopic abnormalities in the organs.- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 for both male and female rats was > 2000 mg/kg bw.
- Executive summary:
This study examined the acute oral toxicity of the test substance to rats. A group of 5 male and 5 female rats were given a dose of 2000 mg/kg bw test substance. The rats were then monitored over the next 14 days for clinical signs and mortality. Body weights were taken on days 0, 7, and 14 of the study. At the termination of the study, all animals were sacrificed, and examined for macroscopic abnormalities. No animals died during the study. No adverse effects to body weight or clinical signs were noted. The acute oral LD50 for male and female rats was > 2000 mg/kg bw. The test substance is not classified as toxic under EU GHS guidelines.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Key study is acute oral toxicity study, reliable without restriction.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1991
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study.
- Qualifier:
- according to guideline
- Guideline:
- other: Sema. 1988. Manual of tests for assessing chemical agents toxicity, 1 ed. Brasilia: MHU.
- GLP compliance:
- no
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 241-267 g males, 180-208 g females
- Housing: conventional breeding station
- Diet (e.g. ad libitum): available
- Water (e.g. ad libitum): available
ENVIRONMENTAL CONDITIONS
- Photoperiod (hrs dark / hrs light): 12 hrs light/12 hrs dark - Type of coverage:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 35-53 cm2 males; 33-42 cm2 females
- % coverage: less than 10% of body surface
- Type of wrap if used: Elizabethan collars were placed on animals to prevent ingestion of test substance.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): yes
- Time after start of exposure: 24 hrs
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 1 ml
- Constant volume or concentration used: yes - Duration of exposure:
- 24 hrs
- Doses:
- 0, 3600 (males), or 4300 mg/kg (females)
- No. of animals per sex per dose:
- Five of each sex per dose were tested.
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observations were made daily, body weights were taken every 7 days
- Necropsy of survivors performed: yes - Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 4 300 mg/kg bw
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 3 600 mg/kg bw
- Mortality:
- No animals died during the study.
- Clinical signs:
- other: No adverse clinical signs were seen during the study.
- Gross pathology:
- No abnormal pathological finding were noted.
- Other findings:
- Doses up to 4300 mg/kg did not cause death or produce clinical, behavioral, or anatomical alterations in female rats. Doses up to 3600 mg/kg bw did not produce adverse effects in male rats.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The dermal LD50 in female rats was > 4300 mg/kg bw, and in male rats was > 3600 mg/kg bw.
- Executive summary:
This study examined the acute dermal toxicity of heavy alkylates. Groups of 5 male and 5 female rats were exposed to concentrations of 0, 3600 (males), and 4300 mg/kg bw (females) dermally. Animals were observed for the next 14 days for mortality and clinical signs. Animals were weighed every 7 days. At the end of the study, animals were necropsied. No animals died during the study, and no adverse clinical signed were noted. Body weight gains of treated animals were also comparable to controls. The acute dermal LD50 for both female rats was > 4300 mg/kg bw, and male rats was > 3600 mg/kg bw.
Reference
Average Body Weight Gain (g)
Control |
3600 mg/kg bw (males) 4300 mg/kg bw (females) |
|
Males |
17.2 |
33.0 |
Females |
12.4 |
13.4 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 600 mg/kg bw
- Quality of whole database:
- Key study is acute dermal toxicity study, reliable with restrictions.
Additional information
Justification for classification or non-classification
HAB is not expected to be acutely toxic, based on the absence of mortality or clinical signs in oral and dermal exposure studies with very high limit doses. Inhalation is not considered to be a relevant route of exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.